major-depressive-disorder

Documents about major-depressive-disorder

• Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment#969063ClinicalTrials.gov
• A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder#993596ClinicalTrials.gov
• Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder#993745ClinicalTrials.gov
• A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder#825662ClinicalTrials.gov
• Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder#915218ClinicalTrials.gov
• Combined sleep deprivation and light therapy for depression in major depressive disorder and bipolar disorder#928104OSF
• qEEG Brain Signature of Depression & Neuromodulation-induced Recovery#852783ClinicalTrials.gov
• Hyperthermic Yoga for Depressive Symptoms#1009525ClinicalTrials.gov
• Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.#1033079ClinicalTrials.gov
• Blood Biomarkers in Major Depression#895583ClinicalTrials.gov
• Spinal Cord Stimulation for the Treatment of Major Depressive Disorder#803789ClinicalTrials.gov
• Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment#806617ClinicalTrials.gov
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder#843030ClinicalTrials.gov
• A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode#844260ClinicalTrials.gov
• Vulnerability Markers for Depression#866247ClinicalTrials.gov
• Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation#866419ClinicalTrials.gov
• A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder#887088ClinicalTrials.gov
• Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders#887865ClinicalTrials.gov
• Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder#908939ClinicalTrials.gov
• Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale#992974ClinicalTrials.gov
• Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression#830600ClinicalTrials.gov
• Ketamine for Relapse Prevention in Recurrent Depressive Disorder#1010360ClinicalTrials.gov
• EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT#867814ClinicalTrials.gov
• A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise#910505ClinicalTrials.gov
• Major Depressive Disorder (MDD)#831594ClinicalTrials.gov
• Phenotype Depression Study#843158ClinicalTrials.gov
• Retrospective Observational Study DIANA Study#804386ClinicalTrials.gov
• The role of zinc homeostasis in major depressive disorder: heterogeneous pathological mechanisms and therapeutic implications#4758Europe PMC
• Immune-related biomarkers for major depressive disorder identified via integrated bioinformatics and machine learning.#9715PubMed
• Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers.#258762PubMed
• A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder#800246ClinicalTrials.gov
• Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder#804090ClinicalTrials.gov
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder#813916ClinicalTrials.gov
• The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy#843285ClinicalTrials.gov
• A Transdiagnostic Sleep and Circadian Treatment for Major Depressive Disorder#846226ClinicalTrials.gov
• Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder#1010374ClinicalTrials.gov
• Repetitive Transcranial Magnetic Stimulation Trajectory of Outcomes Study#1033578ClinicalTrials.gov
• Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive Disorder#915646ClinicalTrials.gov
• LHC-CIDI-5 in Hong Kong#888070ClinicalTrials.gov
• Immune-related biomarkers for major depressive disorder identified via integrated bioinformatics and machine learning#4638Europe PMC
• Relationship between major depressive disorder and venous thromboembolism: a five-ancestry genetic analysis.#219406PubMed
• The Role of mGluR5 in CBT-I#800917ClinicalTrials.gov
• Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder#811582ClinicalTrials.gov
• Accelerated Versus Standard Intermittent Theta Burst Stimulation for Major Depressive Disorder#911186ClinicalTrials.gov
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)#978793ClinicalTrials.gov
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study#1007812ClinicalTrials.gov
• Mindfulness Engaged Neurostimulation for Depression (MEND II)#862655ClinicalTrials.gov
• Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders#892561ClinicalTrials.gov
• Cognitive Functioning in First Episode and Recurrent Major Depressive Disorder: A Systematic Review and Meta-analysis of Comparative Performance#439855OSF
• Resting-state Functional Connectivity Throughout a Course of iTBS in Major Depression#892905ClinicalTrials.gov